ANXIETY - ANXIOLYTIC EFFECTS

ANXIETY - ANXIOLYTIC EFFECTS:

• 2024
• Cannabidiol (CBD) products: Use patterns and perceptions within a sample of anxious users. https://www.tandfonline.com/doi/full/10.1080/10826084.2024.2369153 
• Evaluation of the efficacy, safety and pharmacokinetics of nano-dispersible cannabidiol oral solution (150mg/ml) versus placebo in mild to moderate anxiety subjects: A double blind, multi-center randomized clinical trial. https://pubmed.ncbi.nlm.nih.gov/38797087/ 
• Acute Effects of Cannabigerol on Anxiety, Stress and Mood: A double-blind, placebo-controlled, crossover field study.  https://assets-eu.researchsquare.com/files/rs-4213847/v1_covered_4e497302-c2ec-412c-8bab-67e9ffc157b9.pdf?c=1715833873& 
• Cannabinoids in the treatment of selected mental illnesses: practical approach and overview of the literature. https://www.thieme-connect.de/products/ejournals/html/10.1055/a-2256-0098 
• Acute and Extended anxiolytic effects of cannabidiol in cannabis flower: A Quasi-experimental ad libitum use study. https://www.liebertpub.com/doi/abs/10.1089/can.2023.0187 
• 2023:
• An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry. https://onlinelibrary.wiley.com/doi/10.1002/npr2.12403 
• The impact of a focused behavioral intervention on brain cannabinoid signaling and interoceptive function: Implications for mood and anxiety. https://www.sciencedirect.com/science/article/pii/S294983412300034X 
• Cannabidiol improves learning and memory deficits and alleviates anxiety in 12 month old SAMP8 Mice. https://www.biorxiv.org/content/10.1101/2023.12.21.572902v1.abstract 
• A cohort study comparing the effects of medicinal cannabis for anxiety patients with and without co-morbid sleep disturbances. https://onlinelibrary.wiley.com/doi/10.1002/npr2.12407 
• Daily Diary study of associations between alcohol, cannabis, co-use and sleep quality in individuals with intentions to use and cannabis to cope with anxiety. https://onlinelibrary.wiley.com/doi/full/10.1111/dar.13778 
• An Individual's Lived Experiences of taking Cannabis-Based Medicinal products (CBMP) to treat Anxiety. https://www.mdpi.com/1660-4601/20/18/6776 
• Physician-Guided medical cannabis treatment for co-morbid anxiety and depression disorders in a Canadian Multidisciplinary clinic: A retrospective review. https://www.endocannabinoidmedicine.com/academicarticle/physician-guided-medical-cannabis-treatment-for-comorbid-anxiety-and-depression-disorders-in-a-canadian-multidisciplinary-clinic-a-retrospective-review/ 
• Anxiety Severity and Prescription Medication utilization in first time medical marijuana users. https://www.sciencedirect.com/science/article/pii/S2666915323002093 
• Naturalistic examination of the anxiolytic effects of medical cannabis and associated gender and age differences in a Canadian cohort. https://pubmed.ncbi.nlm.nih.gov/37296470/ 
• The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized, placebo controlled trial. https://pubmed.ncbi.nlm.nih.gov/37552290/ 
• A review of how cannabinoids regulate anxiety, fear & trauma
  Cannabinoid Regulation of Fear and Anxiety: an Update
  https://pubmed.ncbi.nlm.nih.gov/31030284/
• Quality of life among patients using cannabis to manage anxiety: A longitudinal observational study. https://www.endocannabinoidmedicine.com/academicarticle/quality-of-life-among-patients-using-cannabis-to-manage-anxiety/ 
• The Effectiveness and Adverse events of cannabidiol and tetrahydrocannabinol used in the treatment of anxiety disorders in a PTSD subpopulation: An interim analysis of an observational study. https://journals.sagepub.com/doi/full/10.1177/87551225231180796 
• Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK medical cannabis registry. https://link.springer.com/article/10.1007/s00213-023-06399-3 
• Best strains and terpenes for anxiety: https://cannigma.com/strain/best-strains-and-terpenes-for-anxiety/?utm_source=The%20Cannigma%20B2B&utm_medium=email&utm_campaign=Newsletter%2016.05.23%20%2801H0CN6Y1H4AMHXCT1KMYNCMFG%29&_kx=_uv58WsEi9s6bfI1NDeC26zVRyr2jgRfDXqxHEq9LD4%3D.J8JtEm
• Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial: https://www.nature.com/articles/s43856-022-00202-8
• 2022:
• 5 Best Terpenes for Anxiety: https://cannabistraininguniversity.com/medical/terpenes-anxiety/?vgo_ee=4n9pE%2BQmQ9VaMuliLHxtgr35hO7C%2FF3J%2FgQB9Uu3XAY%3D
• Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial (Berger et al, 2022) https://pubmed.ncbi.nlm.nih.gov/35921510/
• Flower Power": Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK patients. https://www.mdpi.com/2227-9059/10/10/2576 
• 2021:
• Study shows cannabinoid signalling vital for anxiety and stress levels:  http://www.healtheuropa.eu/study-shows-cannabinoid-signalling-vital-for-anxiety-and-stress-levels/96811/
• The therapeutic role of Cannabidiol in mental health: a systematic review:  https://link.springer.com/article/10.1186/s42238-019-0012-y#Sec15
• Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers with Social Anxiety Disorders":  https://www.frontiersin.org/articles/10.3389/fpsyg.2019.02466/abstract
• Study: Patients Stopped Using Benzodiazepines Once They Began Consuming Medical Cannabis: https://thefreshtoast.com/cannabis/study-patients-stopped-using-benzodiazepines-once-they-began-consuming-medical-cannabis/#utm_source=rss 
• 2020
• Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. (Australia/ UK, full, 2020) https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-019-2409-8 
• Experiencing sexual harassment by males and associated substance use & poor mental health outcomes among adolescent girls in the US. (USA, full, 2020) https://www.sciencedirect.com/science/article/pii/S2352827318302842?via%3Dihub 
• Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand. (New Zealand, link to PDF, 2020) https://www.researchgate.net/publication/339046590_Cannabidiol_prescription_in_clinical_practice_an_audit_on_the_first_400_patients_in_New_Zealand 
• Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients. (Israel, link to download, 2020) https://www.rmmj.org.il/userimages/1036/1/PublishFiles/1038Article.pdf 
• Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease. (Brazil, abstract, 2020) https://pubmed.ncbi.nlm.nih.gov/31909680/ 
• Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening. (USA, abstract, 2020) https://www.sciencedirect.com/science/article/abs/pii/S0896627319310906 
• First-year French medical students consume antidepressants and anxiolytics while second-years consume non-medical drugs. (France, abstract, 2020) https://www.sciencedirect.com/science/article/abs/pii/S0165032719315514?via%3Dihub 
• Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. (Canada, abstract, 2020) https://www.sciencedirect.com/science/article/abs/pii/S0028390820300319 
• Monoacylglycerol lipase alpha inhibition alters prefrontal cortex excitability and blunts the consequences of traumatic stress in rat. (USA/ Canada, abstract, 2020) https://www.sciencedirect.com/science/article/abs/pii/S0028390820300307?via%3Dihub 
• Dietary intake of polyunsaturated fatty acids alleviates cognition deficits and depressionlike behaviour via cannabinoid system in sleep deprivation rats. (China, abstract, 2020) https://www.sciencedirect.com/science/article/pii/S0166432819317218 
• 2019
• Can cannabinoids help treat obsessive-compulsive disorder? (news/ abst – 2019)
  https://neurosciencenews.com/ocd-cannabinoids-14148/
• Plant-Derived THC/CBD Extracts Reduce Dementia Symptoms Per Study (news – 2019) https://www.weednews.co/plant-derived-thc-cbd-extracts-reduce-dementia-symptoms-per-study/
• Marijuana Makes You Paranoid? Study Suggests Your Genes Are To Blame.
  (news – 2019) https://thefreshtoast.com/cannabis/marijuana-makes-you-paranoid-study-suggests-your-genes-are-to-blame/
• Cannabidiol in Anxiety and Sleep: A Large Case Series. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/ 
• Comorbid tobacco and other substance use and symptoms of anxiety and depression among hospitalised orthopaedic trauma patients. (Australia, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337866/ 
• US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338022/ 
• Characterizing chronic pain in late adolescence and early adulthood: prescription opioids, marijuana use, obesity, and predictors for greater pain interference. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344139/ 
• Cannabinoid and nicotine exposure during adolescence induces sex-specific effects on anxiety- and reward-related behaviors during adulthood. (Netherlands/ USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354968/ 
• Medical Cannabis Use among Adults in the Southeastern United States. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388700/ 
• Patterns of Marijuana Use and Health Impact: A Survey Among Older Coloradans. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487769/ 
• Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice. (Germany, full, 2019) https://www.frontiersin.org/articles/10.3389/fnbeh.2019.00094/full 
• Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804884/ 
• Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms. (USA/ Canada, full, 2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0658?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed& 
• Lavender (Lavandula angustifolia Mill.) Essential Oil Alleviates Neuropathic Pain in Mice With Spared Nerve Injury. (Italy/ Spain, full, 2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00472/full 
• Cannabinoid Regulation of Fear and Anxiety: an Update. (UK, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486906/ 
• FAAH genotype, CRFR1 genotype, and cortisol interact to predict anxiety in an aging, rural Hispanic population: A Project FRONTIER study. (USA, full, 2019) https://www.sciencedirect.com/science/article/pii/S2352289518300997?via%3Dihub 
• Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada. (Canada, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726263/ 
• Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses. (Germany, full, 2019) https://www.nature.com/articles/s41386-018-0274-7 
• Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders. (Japan, full, 2019) https://www.frontiersin.org/articles/10.3389/fpsyg.2019.02466/full 
• Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. (Italy/ UK, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780141/ 
• Chronic nicotine exposure attenuates the effects of Δ9 -tetrahydrocannabinol on anxiety related behavior and social interaction in adult male and female rats. (Canada, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851810/ 
• Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report. (Canada, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944157/ 
• Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry. (Italy/ Greece, full, 2019) https://www.hindawi.com/journals/ecam/2019/2509129/ 
• 24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderateto-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone. (Canada, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839471/ 
• Management of chronic pain with Jalaprakshalana (water-wash) Shodhita (processed) Bhanga (Cannabis sativa L.) in cancer patients with deprived quality of life: An open-label single arm clinical trial. (Jalaprakshalana = water curing until water is clear.- GSC) (India, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891996/ 
• Cannabis tourist destinations: Risk for vulnerable travellers with pre-existing mental disorders. (Israel, link to PDF, 2019) https://academic.oup.com/jtm/article-abstract/27/4/taz098/5671717?redirectedFrom=fulltext 
• Life-long epigenetic programming of cortical architecture by maternal ‘Western’ diet during pregnancy. (Austria/ UK/ Germany/France/ Italy/ Hungary/ Japan/ Canada/ USA/ Sweden, link to PDF, 2019) https://www.researchgate.net/publication/337326915_Life-long_epigenetic_programming_of_cortical_architecture_by_maternal_'Western'_diet_during_pregnancy 
• Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care. (USA, download, 2019) https://www.cannabisskunksense.co.uk/uploads/site-files/Relationship_of_cannabis_use.pdf 
• Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial. (USA, click “cedfoundation” for download, 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Cannabidiol+for+the+Reduction+of+Cue-Induced+Craving+and+Anxiety+in+Drug-Abstinent+Individuals+With+Heroin+Use+Disorder%3A+A+Double-Blind+Randomized+Placebo-Controlled+Trial%22&btnG 
• What are the psychological effects of using synthetic cannabinoids? A systematic review. (UK, click “uclacuk” for download, 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22What+are+the+psychological+effects+of+using+synthetic+cannabinoids%3F+A+systematic+review.%22&btnG 
• Cannabinoids, interoception, and anxiety. (Canada, click “cedfoundation” for download, 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Cannabinoids%2C+interoception%2C+and+anxiety.+%22&btnG 
• Stimulation of Peroxisome Proliferator-Activated Receptor-α by NPalmitoylethanolamine Engages Allopregnanolone Biosynthesis to Modulate Emotional Behavior. (USA, click “researchgate” for download, 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Stimulation+of+Peroxisome+Proliferator-Activated+Receptor-%CE%B1+by+N-Palmitoylethanolamine+Engages+Allopregnanolone+Biosynthesis+to+Modulate+Emotional+Behavior.%22&btnG 
• Use of marijuana exclusively for medical purposes. (USA, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0376871618305660?via%3Dihub 
• Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. (Israel, abstract, 2019) https://www.tandfonline.com/doi/abs/10.1080/13543784.2019.1561859?journalCode=ieid20& 
• Substances as Self-Treatment for Cognitive Test Anxiety among Undergraduate Students. (Israel, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/30657440/ 
• A longitudinal analysis of cannabis use and mental health symptoms among gay, bisexual, and other men who have sex with men in Vancouver, Canada. (Canada/ USA, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0165032718319293?via%3Dihub 
• Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment. (Iran, abstract, 2019) https://www.sciencedirect.com/science/article/pii/S0166432818316735?via%3Dihub 
• Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. (USA, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0277953619303272?via%3Dihub 
• MEDICAL MARIJUANA DEPENDENCE AMONG CHRONIC PAIN PATIENTS SUFFERING FROM DEPRESSION AND ANXIETY. (Israel, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31339242/ 
• A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes. (Hungary/ UK, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0165032719303623?via%3Dihub 
• The endocannabinoid system is affected by cholesterol dyshomeostasis: Insights from a murine model of Niemann Pick type C disease. (Italy, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0969996119301998?via%3Dihub 
• CB1 receptor antagonism in capuchin monkeys alters social interaction and aversive memory extinction. (Brazil/ Japan, abstract, 2019) https://www.semanticscholar.org/paper/CB1-receptor-antagonism-in-capuchin-monkeys-alters-Gonczarowska-Tomaz/d3688af39451da4b7e300c8d3ebbc84d6008fe60 
• Cannabidiol (CBD) use in psychiatric disorders: A systematic review. (UK/ Italy, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0161813X19300774?via%3Dihub 
• Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats. (Brazil, abstract, 2019) https://www.semanticscholar.org/paper/Role-of-the-endocannabinoid-system-in-the-dorsal-in-Hartmann-Fassini/2c6dfc94a40b9880ba2ea5490b6fe16942d70dd7 
• The "entourage effect": Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. (Israel, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31481004/ 
• Role of the kynurenine pathway and the endocannabinoid system as modulators of inflammation and personality traits. (USA/ Canada, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306453019310182?via%3Dihub 
• Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation. (Canada, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31547752/ 
• Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education. (Canada, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31579835/ 
• How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. (UK, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0149763419305615?via%3Dihub 
• Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain. (Poland, abstract, 2019) https://www.semanticscholar.org/paper/Role-of-endocannabinoid-system-in-dopamine-within-Mlost-W%C4%85sik/8ead21c33539fa530f887472c42bec2c88969902 
• Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks. (Brazil, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0028390819300231?via%3Dihub 
• A Novel Role for the Endocannabinoid System in Ameliorating Motivation for Alcohol Drinking and Negative Behavioral Affect after Traumatic Brain Injury in Rats. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/30638118/ 
• Early endocannabinoid system activation attenuates behavioral impairments induced by initial impact but does not prevent epileptogenesis in lithium–pilocarpine status epilepticus model. (Russia, abstract, 2019) https://www.epilepsybehavior.com/article/S1525-5050(18)30727-3/fulltext 
• Phenolic compounds from nutmeg (Myristica fragrans Houtt.) inhibit the endocannabinoid-modulating enzyme fatty acid amide hydrolase. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31595522/ 
• Utilization of medicinal cannabis for pain by individuals with spinal cord injury. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31632724/ 
• Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users. (Canada, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0022395618304783 
• Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments. (Canada, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31675939/ 
• Perceived Efficacy of Medical Cannabis in the Treatment of Co-Occurring HealthRelated Quality of Life Symptoms. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31693457/ 
• Potential new therapies against a toxic relationship: neuroinflammation and Parkinson's disease. (Brazil / Spain, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31703030/ 
• Link between personality and response to THC exposure. (Israel, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31734264/ 
• Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland. (Switzerland, abstract, 2019) https://www.sciencedirect.com/science/article/pii/S0376871619305034?via%3Dihub 
• Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping. (Italy/ Israel, abstract, 2019) https://onlinelibrary.wiley.com/doi/abs/10.1002/dev.21944 
• Use of cannabidiol in anxiety and anxiety-related disorders. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31866386/ 
• Does morning affect contribute to daily Cannabis use? (USA, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S030646031831339X 
• 2018
• Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. (Italy, full in English & French, 2018) https://www.cambridge.org/core/journals/epidemiology-and-psychiatric-sciences/article/pharmacological-properties-of-cannabidiol-in-the-treatment-of-psychiatric-disorders-a-critical-overview/D7FD68F40CF30CBB48A1025C66873F26/core-reader 
• From “Azalla” to Anandamide: Distilling the Therapeutic Potential of Cannabinoids. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752109/ 
• The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents. (France, full, 2018) https://www.nature.com/articles/s41598-018-20895-z 
• Cannabidiol to Improve Mobility in People with Multiple Sclerosis. (USA, full, 2018) https://www.frontiersin.org/articles/10.3389/fneur.2018.00183/full#B19 
• Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. (USA/ Denmark, full, 2018) https://www.nature.com/articles/s41398-018-0141-7 
• 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. (Netherlands/ Italy, full, 2018) https://www.sciencedirect.com/science/article/pii/S0163782717300619?via%3Dihub 
• Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. (Canada/ USA, full, 2018) https://link.springer.com/article/10.1186/s10194-018-0862-2 
• Effect of WIN55-212-2 and Consequences of Extinction Training on Conditioned Fear Memory in PTSD Male Rats. (Iran, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010652/ 
• Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle. (USA/ Spain, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098033/ 
• Substance Use and Psychological Disorders Among Art and Non-art University Students: an Empirical Self-Report Survey. (Hungary/ UK, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814514/ 
• A naturalistic examination of the perceived effects of cannabis on negative affect. (USA, full, 2018) https://www.sciencedirect.com/science/article/pii/S0165032718303100 
• No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. (Brazil, full, 2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00315/full 
• Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007529/ 
• A Cross-Sectional Study of Cannabidiol Users. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043845/ 
• Long-Term Stress and Concomitant Marijuana Smoke Exposure Affect Physiology, Behavior and Adult Hippocampal Neurogenesis. (Hungary, full, 2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00786/full 
• Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials. (Brazil, full, 2018) https://www.frontiersin.org/articles/10.3389/fnins.2018.00502/full 
• Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16). (Australia, full, 2018) https://www.mja.com.au/journal/2018/209/5/medicinal-cannabis-australia-2016-cannabis-medicine-survey-cams-16 
• The Consumption of Cannabis by Fibromyalgia Patients in Israel. (Israel, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081591/ 
• New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders. (Italy/ USA, full, 2018) https://www.mdpi.com/2305-6320/5/4/107/htm 
• Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. (Brazil, full, 2018) https://www.frontiersin.org/articles/10.3389/fimmu.2018.02009/full 
• Evaluating the Long-Term Effectiveness of School-Based Depression, Anxiety, and Substance Use Prevention Into Young Adulthood: Protocol for the Climate School Combined Study. (Australia, full, 2018) https://www.researchprotocols.org/2018/11/e11372/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+ResProtoc+%28JMIR+Research+Protocols%29 
• Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain. (Canada/ Italy/ USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319597/ 
• The association between depression, anxiety and substance use among Canadian postsecondary students. (Canada, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260190/ 
• Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness. (USA, full, 2018) https://ascopubs.org/doi/full/10.1200/EDBK_209437?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed& 
• Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal. (Spain, full, 2018) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.14226 
• Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake. (USA/ Spain, full, 2018) https://www.nature.com/articles/s41386-018-0055-3 
• Medicinal versus Recreational Cannabis Use among Returning Veterans. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037171/ 
• Reduced Nicotine Content Cigarettes and Cannabis Use in Vulnerable Populations. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219758/ 
• The association between adolescent cannabis use and anxiety: A parallel process analysis. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819339/ 
• Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer. (Canada, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248184/ 
• The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety among Youth under 25 Years. (Canada, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591882/ 
• Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer's Disease. (Italy, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343203/ 
• The impact of PTSD clusters on cannabis use in a racially diverse trauma-exposed sample: An analysis from ecological momentary assessment. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294292/ 
• Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice. (USA/ Netherlands, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955845/ 
• Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202263/ 
• Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2. (Brazil/ USA, full, 2018) https://www.nature.com/articles/s41386-018-0064-2 
• The Lateral Habenula Directs Coping Styles Under Conditions of Stress Via Recruitment of the Endocannabinoid System. (USA/ Canada/ Spain, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162143/ 
• Itch and psyche: psychiatric aspects of pruritus. (USA, full, 2018) https://onlinelibrary.wiley.com/doi/full/10.1111/ijd.14081 
• Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157909/ 
• Sex Differences in the Association Between Cannabis Use and Suicidal Ideation and Attempts, Depression, and Psychological Distress Among Canadians. (Canada, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591888/ 
• Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476562/ 
• Integrating endocannabinoid signaling in the regulation of anxiety and depression. (China/ Canada, full, 2018) https://www.nature.com/articles/s41401-018-0051-5 
• Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects. (Italy, link to full, 2018) https://www.hindawi.com/journals/ecam/2018/1709182/ 
• Stress responding in cannabis smokers as a function of trauma exposure, sex, and relapse in the human laboratory. (USA/ Australia) (link to PDF – 2018) https://www.researchgate.net/publication/322827696_Stress_responding_in_cannabis_smokers_as_a_function_of_trauma_exposure_sex_and_relapse_in_the_human_laboratory 
• Relationships between substance abuse/dependence and psychiatric disorders based on polygenic scores. (Spain, link to PDF, 2018) https://www.semanticscholar.org/paper/Associations-between-Polygenic-Risk-for-Psychiatric-Carey-Agrawal/7efd0879f4a8da6a6043f52cdf2dcb1dbe4958b7 
• Anxiety sensitivity components in relation to alcohol and cannabis use, motives, and problems in treatment-seeking cigarette smokers. (USA, link to PDF, 2018) https://www.researchgate.net/publication/323636835_Anxiety_sensitivity_components_in_relation_to_alcohol_and_cannabis_use_motives_and_problems_in_treatment-seeking_cigarette_smokers 
• Trajectories of alcohol and marijuana use among primary versus secondary psychopathy variants within an adjudicated adolescent male sample. (USA, link to PDF, 2018) https://www.researchgate.net/publication/326856425_Trajectories_of_Alcohol_and_Marijuana_Use_Among_Primary_Versus_Secondary_Psychopathy_Variants_Within_an_Adjudicated_Adolescent_Male_Sample 
• Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD. (Israel/ USA, link to PDF, 2018) https://www.researchgate.net/publication/323566085_Chronic_treatment_with_URB597_ameliorates_post-stress_symptoms_in_a_rat_model_of_PTSD 
• Association of Cannabis With Long-Term Clinical Symptoms in Anxiety and Mood Disorders: A Systematic Review of Prospective Studies. (Canada/ Israel, link to PDF, 2018) https://www.researchgate.net/publication/325589498_Association_of_Cannabis_With_Long-Term_Clinical_Symptoms_in_Anxiety_and_Mood_Disorders_A_Systematic_Review_of_Prospective_Studies 
• Effects of central RVD-hemopressin(α) administration on anxiety, feeding behavior and hypothalamic neuromodulators in the rat. (Italy/ Hungary, link to PDF, 2018) https://www.researchgate.net/publication/322893957_Effects_of_central_RVD-hemopressina_administration_on_anxiety_feeding_behavior_and_hypothalamic_neuromodulators_in_the_rat 
• The endocannabinoid system in mental disorders: Evidence from human brain studies. (Spain, link to PDF, 2018) https://www.researchgate.net/publication/326451892_The_endocannabinoid_system_in_mental_disorders_Evidence_from_human_brain_studies 
• Affect and cannabis use in daily life: a review and recommendations for future research. (USA, link to PDF, 2018) https://www.researchgate.net/publication/327038512_Affect_and_cannabis_use_in_daily_life_a_review_and_recommendations_for_future_research 
• Cannabis Use in Individuals with Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado. (USA, download, 2018) https://www.cedfoundation.com/wp-content/uploads/2019/10/Cannabis-Use-in-Individuals-with-Spinal-Cord-Injury-or-Moderate-to-Severe-Traumatic-Brain-Injury-in-Colorado.pdf 
• Developmental pathways of adolescent cannabis use: Risk factors, outcomes and sex specific differences. (USA, click “researchgate” for download, 2018) https://scholar.google.com/scholar?q=%22Developmental+pathways+of+adolescent+cannabis+use:+Risk+factors,+outcomes+and+sex-specific+differences.%22&hl=en&as_sdt=0&as_vis=1&oi=scholart 
• Maternal separation increases alcohol-drinking behaviour and reduces endocannabinoid levels in the mouse striatum and prefrontal cortex. (Spain, click “upf” for download, 2018)https://scholar.google.com/scholar?q=%22Maternal+separation+increases+alcohol-drinking+behaviour+and+reduces+endocannabinoid+levels+in+the+mouse+striatum+and+prefrontal+cortex%22&hl=en&as_sdt=0&as_vis=1&oi=scholart 
• Anxiety sensitivity and cannabis use problems, perceived barriers for quitting, and fear of quitting. (USA, click “mariarobles” for download, 2018) https://scholar.google.com/scholar?q=%22Anxiety+sensitivity+and+cannabis+use+problems,+perceived+barriers+for+quitting,+and+fear+of+quitting%22&hl=en&as_sdt=0&as_vis=1&oi=scholart 
• Maltreatment, attachment, and substance use in adolescence: Direct and indirect pathways. (Canada, click “adolescenthealthca” for download, 2018) https://scholar.google.com/scholar?q=%22Maltreatment,+attachment,+and+substance+use+in+adolescence:+Direct+and+indirect+pathways%22&hl=en&as_sdt=0&as_vis=1&oi=scholart 
• Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review. (UK, click “kclacuk” for download, 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Spicing+it+up+-+synthetic+cannabinoid+receptor+agonists+and+psychosis+-+a+systematic+review.%09%22&btnG 
• Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus. (Spain, click the “holistichempextracts” link for download, 2018) https://scholar.google.com/scholar?cluster=1903421415094504147&hl=en&as_sdt=0,5&as_vis=1 
• Direct and indirect effects of false safety behaviors on cannabis use and related problems. (USA, abstract, 2018) https://www.semanticscholar.org/paper/Direct-and-indirect-effects-of-false-safety-on-use-Buckner-Zvolensky/2c1f6e7fa50324a4544176a4a1ec279eb972fad8 
• Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats. (Italy, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0028390818300510 
• Functional effects of synthetic cannabinoids versus Δ9 -THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor/exploratory parameters and depression. (Israel, abstract, 2018) https://www.semanticscholar.org/paper/Functional-effects-of-synthetic-cannabinoids-versus-Schreiber-Bader/bdcc732eca01fb98bf65981d65180ad3c9839dd5 
• Sacred Maya incense, copal (Protium copal - Burseraceae), has antianxiety effects in animal models. (Canada/ Belize, abstract, 2018) http://www.shaman-australis.com/forum/index.php?/topic/45283-some-research-on-amyrins-and-resins/ 
• Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study. (Israel/ Canada/ Germany, abstract, 2018) https://pubmed.ncbi.nlm.nih.gov/29486095/ 
• Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC. (UK, abstract, 2018) https://pubmed.ncbi.nlm.nih.gov/29502548/ 
• The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling. (Brazil/ USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0028390818301023?via%3Dihub 
• Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study. (Germany, abstract, 2018) https://pubmed.ncbi.nlm.nih.gov/29546791/ 
• Circulating endocannabinoids and affect regulation in human subjects. (USA/ Canada, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306453017315470 
• Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study. (France/ USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0376871618302011 
• Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice. (Argentina, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0028390818302417 
• The relationship of endocannabinoidome lipid mediators with pain and psychological stress in women with fibromyalgia – a case control study. (Sweden, abstract, 2018) https://www.jpain.org/article/S1526-5900(18)30197-4/fulltext 
• FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats. (Ireland, abstract, 2018) https://www.sciencedirect.com/science/article/pii/S016643281830250X?via%3Dihub 
• Orbitofrontal connectivity is associated with depression and anxiety in marijuana-using adolescents. (USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0165032718300557 
• Sex-specific effects of CB1 receptor antagonism and stress in adolescence on anxiety, corticosterone concentrations, and contextual fear in adulthood in rats. (Canada, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0736574818301758?via%3Dihub 
• Residual effects of cannabis use on attentional bias towards fearful faces. (USA/ UK, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0028393218306201?via%3Dihub 
• Interrelationships among depression, anxiety, flourishing, and cannabis use in youth. (Canada, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318304301 
• DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults. (Israel/ USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0376871618307142 
• Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood. (Spain, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0028390818308517?via%3Dihub 
• Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors. (Canada, abstract, 2018) https://www.semanticscholar.org/paper/%CE%94-9-Tetrahydrocannabinol-and-Cannabidiol-produce-on-Szkudlarek-Desai/4d996f4ca45cfbb64253ea7f3a6566162e2c994b 
• Predictors of drug use during pregnancy: The relative effects of socioeconomic, demographic, and mental health risk factors. (Canada, abstract, 2018) https://content.iospress.com/articles/journal-of-neonatal-perinatal-medicine/npm1814 
• Associations between marijuana use and anxious mood lability during adolescence. (USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318311729?via%3Dihub   
• 2017
• Changes in the Brain Endocannabinoid System in Rat Models of Depression. (Poland, full, 2017) https://link.springer.com/article/10.1007/s12640-017-9708-y 
• Endocannabinoids: A Promising Impact for Traumatic Brain Injury. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/ 
• Precondition of right frontal region with anodal tDCS can restore the fear memory impairment induced by ACPA in male mice. (Iran, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318674/ 
• Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury. (USA, full, 2017) https://www.frontiersin.org/articles/10.3389/fphar.2017.00095/full 
• Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. (Brazil/ Spain/ USA, full, 2017) https://www.frontiersin.org/articles/10.3389/fphar.2017.00269/full 
• The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in dietinduced obese pre-diabetic mice. (Spain/ UK/ Brazil, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479807/ 
• The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress. (China, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553743/ 
• Cannabis as a substitute for prescription drugs - a cross-sectional study. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422566/ 
• An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. (Germany, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/ 
• Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons. (Germany, full, 2017) https://link.springer.com/article/10.1007%2Fs00429-017-1411-5 
• Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats. (Iran, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440922/ 
• Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment. (France/ USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581875/ 
• A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders. (Singapore, full, 2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301 
• Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation. (Spain, full, 2017) https://www.frontiersin.org/articles/10.3389/fnbeh.2017.00015/full 
• Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to LongTerm Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655843/ 
• Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors. (UK/ Republic of Korea, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670208/ 
• The Endocannabinoid System Differentially Regulates Escape Behavior in Mice. (Germany, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655002/ 
• Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. (USA/ Japan/ Brazil, full, 2017) https://www.nature.com/articles/s41598-017-17796-y 
• Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents. (Canada/ China, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487270/ 
• Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders. (UK/ Brazil, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595771/ 
• Anxious behavior induces elevated hippocampal Cb2 Receptor gene expression. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482502/ 
• Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype. (USA/ Italy, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509512/ 
• Increased in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis. (USA/ Australia, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545681/ 
• Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515287/ 
• Mechanisms Underlying Sex Differences in Cannabis Use. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828236/ 
• Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572754/ 
• The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719094/ 
• Acute and long-term effects of Δ9-tetrahydrocannabinol on object recognition and anxiety-like activity are age- and strain-dependent in mice. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690484/ 
• Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids imbalance. (France, full, 2017) https://www.jneurosci.org/content/37/29/6851.full 
• CB1 and ethanol effects on glutamatergic transmission in the central amygdala of male and female msP and Wistar rats. (USA/ Italy, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745318/ 
• Pharmacological challenge studies with acute psychosocial stress. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623124/ 
• Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid expression of innate anxiety and excessive alcohol intake. (Italy/ USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625509/ 
• Becoming a Medical Marijuana User. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808850/ 
• Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls. (Canada, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603819/ 
• Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety. (USA/ Denmark, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585044/ 
• Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. (USA/ Canada/ Italy, full, 2017) https://www.nature.com/articles/npp2017162 
• Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use in older adults with and without HIV infection. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920804/ 
• Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced Suppression of Excitation in the Anterior Cingulate Cortex. (China, full, 2017) https://academic.oup.com/cercor/article/28/6/2118/3829385 
• Addison’s Disease and Possible Cannabis Withdrawal Syndrome Presenting as an Eating Disorder in a Thirty-Year-Old Female. (Canada, link to full, 2017) https://www.hindawi.com/journals/crie/2017/4096021/ 
• Repeated Acute Oral Exposure to Cannabis sativa Impaired Neurocognitive Behaviours and Cortico-hippocampal Architectonics in Wistar Rats. (Nigeria, link to PDF, 2017) https://www.researchgate.net/publication/314242786_Repeated_Acute_Oral_Exposure_to_Cannabis_sativa_Impaired_Neurocognitive_Behaviours_and_Cortico-hippocampal_Architectonics_in_Wistar_Rats 
• The effects of synthetic cannabinoids on executive function. (Israel/ Hungary, link to PDF, 2017) https://www.researchgate.net/publication/313320166_The_effects_of_synthetic_cannabinoids_on_executive_function 
• Endocannabinoid mechanism in amphetamine-type stimulant use disorders: A short review. (China, link to PDF, 2017) https://www.researchgate.net/publication/319647666_Endocannabinoid_mechanism_in_amphetamine-type_stimulant_use_disorders_A_short_review 
• Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels. (USA, link to PDF, 2017) https://www.researchgate.net/publication/315436386_Endocannabinoid_and_Mood_Responses_to_Exercise_in_Adults_with_Varying_Activity_Levels 
• Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA. (Australia, link to PDF, 2017) https://www.researchgate.net/publication/312491240_Acute_and_residual_effects_in_adolescent_rats_resulting_from_exposure_to_the_novel_synthetic_cannabinoids_AB-PINACA_and_AB-FUBINACA 
• The Direct Actions of Cannabidiol and 2-Arachidonoyl Glycerol at GABAA Receptors. (Australia, link to PDF, 2017) https://www.researchgate.net/publication/314109989_The_Direct_Actions_of_Cannabidiol_and_2-Arachidonoyl_Glycerol_at_GABAA_Receptors 
• Synthetic Cannabinoids: psychopharmacology, clinical aspects, and psychotic onset. (Italy/ UK, link to PDF, 2017) https://www.semanticscholar.org/paper/Synthetic-Cannabinoids%3A-Psychopharmacology%2C-Onset.-Martinotti-Santacroce/eaf68bab1fb1fffe2971635f0d3bc68c9309f2ac 
• Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus. (USA, link to PDF, 2017) https://www.researchgate.net/publication/319568811_Distinct_roles_of_neuronal_and_microglial_CB2_cannabinoid_receptors_in_the_mouse_hippocampus 
• Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats. (Italy/ Hungary, link to PDF, 2017) https://www.researchgate.net/publication/317858765_Emotional_disorders_induced_by_Hemopressin_and_RVD-hemopressina_administration_in_rats 
• Contribution of CB1Rs in anxiety-related behaviors but not locomotor deficits induced by methamphetamine. (Iran, link to PDF, 2017) https://www.researchgate.net/publication/321739457_Contribution_of_CB1Rs_in_anxiety-related_behaviors_but_not_locomotor_deficits_induced_by_methamphetamine 
• Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. (USA, click “komornlaw” for download, 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Substitution+of+medical+cannabis+for+pharmaceutical+agents+for+pain%2C+anxiety%2C+and+sleep+&btnG 
• User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate. (Australia/ UK, click “uclacuk” for download, 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22User+characteristics+and+effect+profile+of+Butane+Hash+Oil%3A+An+extremely+high-potency+%09cannabis+concentrate.+%22&btnG 
• Substance Use in Young Swiss Men: The Interplay of Perceived Social Support and Dispositional Characteristics. (Switzerland/ Canada/ UK, click “coreacuk” for download, 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Substance+Use+in+Young+Swiss+Men%3A+The+Interplay+of+Perceived+Social+Support+and+Dispositional+Characteristics.%22&btnG 
• The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit. (Israel, click “academia” for download, 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22The+involvement+of+cannabinoids+and+mTOR+in+the+reconsolidation+of+an+emotional+memory+in+the+hippocampal%E2%80%93amygdala%E2%80%93insular+circuit%22&btnG 
• Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model of social isolation stress. (Iran, click “skumacir” for download, 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Activation+of+cannabinoid+receptors+elicits+antidepressant-like+effects+in+a+mouse+model+of+social+isolation+stress.+++%22&btnG 
• Is cannabis treatment for anxiety, mood, and related disorders ready for prime time? (Canada, click “therocus” for download, 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Is+cannabis+treatment+for+anxiety%2C+mood%2C+and+related+disorders+ready+for+prime+time%3F%22&btnG 
• Genetic association analyses of the endocannabinoid system on anxious phenotype. (Hungary, link to abstract in English at bottom of page, full in Hungarian, 2017) http://mppt-nph.hu/images/magazin/pdf/xix-evfolyam-4-szam/lazary_eredeti_honlapra.pdf 
• Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders. (USA, abstract, 2017) https://jamanetwork.com/journals/jama/article-abstract/2610319 
• Association of cannabis use with the development of elevated anxiety symptoms in the general population: a meta-analysis. (UK, abstract, 2017) https://pubmed.ncbi.nlm.nih.gov/28053188/ 
• Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus. (Czech Republic/ Germany/ Italy, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0022395616308469?via%3Dihub 
• Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. (Israel, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0165032716320018?via%3Dihub 
• An update on the advancements in the treatment of agitation in Alzheimer's disease. (USA, abstract, 2017) https://www.tandfonline.com/doi/abs/10.1080/14656566.2017.1307340?journalCode=ieop20& 
• Cannabinoids as therapeutic for PTSD. (USA, abstract, 2017) https://www.sciencedirect.com/science/article/pii/S2352250X16302342 
• Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats. (Canada/ Israel, abstract, 2017) https://link.springer.com/article/10.1007/s00213-017-4626-5 
• The endocannabinoid system as a target for novel anxiolytic drugs. (USA/ Canada/ Germany, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0149763416304699 
• 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex. (Brazil, abstract, 2017) https://www.semanticscholar.org/paper/2-Arachidonoylglycerol-endocannabinoid-signaling-to-Almeida-Santos-Moreira/a254621a26420305e495cdf677aec58471e22e0e 
• Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems. (Italy, abstract, 2017) https://www.semanticscholar.org/paper/Altered-responses-of-dopamine-D3-receptor-null-mice-Micale-Cristino/e33564365e31533850f991a2fcd0dc95e54bb8b6 
• Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum. (Italy, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0969996117301717?via%3Dihub 
• Is there a role for cannabidiol in psychiatry? (Brazil/ France, abstract, 2017) https://pubmed.ncbi.nlm.nih.gov/28112021/ 
• Enhanced anandamide signaling reduces flight behavior elicited by an approaching robobeetle. (Germany, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0028390817304276?via%3Dihub 
• Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia. (Canada, abstract, 2017) https://pubmed.ncbi.nlm.nih.gov/29256923/ 
• Marijuana use during pregnancy: A comparison of trends and correlates among married and unmarried pregnant women. (USA, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0376871617305318 
• Chapter Eight – The Endocannabinoid System and Anxiety. (Brazil/ USA, abstract, 2017) https://www.sciencedirect.com/science/article/pii/S0083672916300486?via%3Dihub 
• 10 Types Of Marijuana That Will Make You Feel More Peaceful (news–2017)  https://thefreshtoast.com/cannabis/10-types-of-marijuana-that-will-make-you-feel-more-peaceful/#sthash.aZd1GnMh.dpuf
• Natural cannabinoid found to play key role in anxiety (news–2017) http://www.medicalnewstoday.com/articles/316682.php
• A Veteran Returned Home With PTSD And Pain, So He Became A Medical Marijuana Patient (news–2017) http://www.huffingtonpost.com/entry/leo-bridgewater-medical-marijuana-vets-ptsd_us_58fe630fe4b018a9ce5dd083
• CBD Oil Actually Helped With My Anxiety (news–2017) http://nymag.com/thecut/2017/04/what-cannabidiol-oil-did-for-me.html
• Consequences of pot program cuts ‘should be alarming,’ says veteran with PTSD (news–2017) http://www.cbc.ca/news/canada/nova-scotia/medical-marijuana-program-veterans-affairs-fabian-henry-ptsd-1.4119940
• How My Brief Encounter with Marijuana is Still Helping My Anxiety, Years Later (news–2017) https://thebolditalic.com/how-one-hit-of-weed-saved-my-life-497b9c676725
• Las Vegas’ latest marijuana trend: enhanced yoga (news–2017) https://lasvegassun.com/news/2017/jun/05/las-vegas-latest-weed-trend-marijuana-and-yoga/
• Why Some People Can’t Handle Their Weed (news–2017)
  https://www.vice.com/en_us/article/why-some-people-cant-handle-their-weed
• How marijuana edibles keeps this guy focused and working (news–2017)
  http://www.salon.com/2017/05/07/how-marijuana-edibles-keeps-this-guy-focused-and-working_partner-2/
• Cannabis is an Effective Treatment for PTSD (news–2017) https://www.marijuanatimes.org/cannabis-is-an-effective-treatment-for-ptsd/
• I Tried CBD Oil to Calm My Nerves While Flying, and This Is What Happened (news–2017) https://www.popsugar.com/smart-living/Does-CBD-Oil-Calm-You-Down-While-Flying-44103779#comments
• 2016
• Exposure to a Highly Caloric Palatable Diet During Pregestational and Gestational Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Adiposity and Anxiety-Like Behaviors in Male Rat Offspring. (Spain/ Germany, full, 2016) https://www.frontiersin.org/articles/10.3389/fnbeh.2015.00339/full 
• Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze. (full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656987/                           
• Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review. (Iran, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726806/ 
• Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats. (USA, full, 2016) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153327 
• Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. (USA, full, 2016) https://elifesciences.org/articles/14137 
• Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders. (UK/ Netherlands/ Australia/Germany/USA/Denmark/ Norway, full, 2016) https://onlinelibrary.wiley.com/doi/full/10.1002/ajmg.b.32467 
• CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory. (USA, full, 2016) https://www.hindawi.com/journals/np/2016/9817089/ 
• Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor. (Japan, full, 2016)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942073/ 
• Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. (Israel/ Brazil, full, 2016) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158779 
• Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress. (France, full, 2016) https://www.cell.com/cell-reports/fulltext/S2211-1247(16)30851-8 
• Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. (Italy/ Germany, full, 2016) https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0682-8 
• Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring. (Spain/ Germany, full, 2016) https://www.frontiersin.org/articles/10.3389/fnbeh.2016.00208/full 
• Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders. (UK/ Brazil, full, 2016) https://www.frontiersin.org/articles/10.3389/fphar.2016.00454/full 
• Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147424/ 
• Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/ 
• Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood. (Israel, full, 2016) http://learnmem.cshlp.org/content/23/7/349.long 
• Solitary cannabis use frequency mediates the relationship between social anxiety and cannabis use and related problems. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147422/ 
• The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado. (USA, full, 2016) https://peerj.com/articles/2782/ 
• Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid. (Japan, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993868/ 
• Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/ 
• Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869705/ 
• Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. (Canada/ USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461973/ 
• Interactions Between Anandamide and Corticotropin-Releasing Hormone Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935637/ 
• Evidences for the anti-panic actions of Cannabidiol. (Brazil, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412699/ 
• Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978804/ 
• Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids. (USA/ Canada, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868450/ 
• Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064815/ 
• FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence. (USA/ Sweden, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748341/ 
• Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818147/ 
• Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113710/ 
• Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088172/ 
• Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala. (USA/ Denmark, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956605/ 
• Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma. (Hungary, full, 2016) https://www.sciencedirect.com/science/article/pii/S0924977X16000778 
• Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependent Interaction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus. (China, full, 2016) https://onlinelibrary.wiley.com/doi/full/10.1111/jnc.13613 
• Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks. (Canada/ Australia/ USA/ Spain, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350061/ 
• Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention. (Israel, link to PDF, 2016) https://www.researchgate.net/publication/306434890_Cannabinoids_and_post-traumatic_stress_disorder_clinical_and_preclinical_evidence_for_treatment_and_prevention 
• Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review. (New Zealand, link to PDF, 2016) https://www.researchgate.net/publication/306526731_Signs_and_symptoms_associated_with_synthetic_cannabinoid_toxicity_Systematic_review 
• Pharmacological inhibition of FAAH activity in rodents: a promising pharmacological approach for psychological - cardiac comorbidity? (Italy/ Australia/ USA, link to PDF, 2016) https://www.researchgate.net/publication/301734639_Pharmacological_inhibition_of_FAAH_activity_in_rodents_A_promising_pharmacological_approach_for_psychological-cardiac_comorbidity 
• Cannabidiol, neuroprotection and neuropsychiatric disorders. (Brazil, link to download, 2016) https://static1.squarespace.com/static/57faf399cd0f68a69b4c670c/t/5839e5e4e58c622c253519e9/1480189413826/Cannabidiol%2C+neuroprotection+and+neuropsychiatric+disorders.pdf 
• The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats. (Hungary, click “mtakhu” for download, 2016)https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22The+effects+anandamide+signaling+in+the+prelimbic+cortex+and+basolateral+amygdala+on+coping+with+environmental+stimuli+in+rats%22&btnG 
• Pharmacological management of agitation and aggression in Alzheimer's Disease: a review of current and novel treatments. (Canada, click “academia” for download, 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Pharmacological+Management+of+Agitation+and+Aggression+in+Alzheimer%27s+Disease%3A+A+Review+of+Current+and+Novel+Treatments.%22&btnG 
• Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study. (Israel, click “academia” for download, 2016) https://scholar.google.com/scholar?q=Safety+and+Efficacy+of+Medical+Cannabis+Oil+for+Behavioral+and+Psychological+Symptoms+of+Dementia:+An-Open+Label,+Add-On,+Pilot+Study&hl=en&as_sdt=0&as_vis=1&oi=scholart
• Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor. (Iran/ UK, click “readingacuk” for download, 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Cannabinoid+receptor+agonism+suppresses+tremor%2C+cognition+disturbances+and+anxiety-like+behaviors+in+a+rat+model+of+essential+tremor%22&btnG 
• Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia. (Brazil, click “researchgate” for download, 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Cannabidiol+reduces+neuroinflammation+and+promotes+neuroplasticity+and+functional+recovery+after+brain+ischemia%22&btnG 
• Medical cannabis and mental health: A guided systematic review. (Canada/ USA, click “ubcca” for download, 2016) https://scholar.google.com/scholar?q=Medical+cannabis+and+mental+health:+A+guided+systematic+review&hl=en&as_sdt=0&as_vis=1&oi=scholart 
• The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models. (USA, 1st page, 2016) https://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00532-6/fulltext 
• Placebo effect: clinical, biological and therapeutical involvements in depression. (France, abstract in English & French, 2016) https://www.em-consulte.com/article/1033101/alertePM
• Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders. (Netherlands, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0960894X16306874 
• Facilitatory effect of AM281 on recognition memory in rats. (Poland, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S1734114015003254 
• Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. (Canada/ USA/ Germany, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0306453016300038 
• A systematic review of plant-derived natural compounds for anxiety disorders. (Iran, abstract, 2016) https://www.eurekaselect.com/139238/article 
• Concentration, population, and context-dependent effects of AM251 in zebrafish. (Canada, abstract, 2016) https://link.springer.com/article/10.1007/s00213-016-4240-y 
• Involvement of M1 and CB1 receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex. (Brazil, abstract, 2016) https://link.springer.com/article/10.1007%2Fs00213-016-4228-7 
• Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal. (USA, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0892036216300101?via%3Dihub 
• Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene. (Netherlands, abstract, 2016) https://onlinelibrary.wiley.com/doi/abs/10.1111/adb.12372 
• CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus. (Brazil, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0028390816301393 
• The association between cannabis use and anxiety disorders: Results from a population based representative sample. (Israel/ Canada, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/26775742/ 
• The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings. (Italy/ Germany, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S104366181630706X 
• Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents. (Australia/ UK, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0376871616301806 
• Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice. (Ethiopia/ USA, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0006899316305431?via%3Dihub 
• Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety. (Canada/ Italy, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0028390816303550 
• Contribution of health motive to cannabis use among high-school students. (France, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0306460316302829 
• Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat. (Germany, abstract, 2016) https://www.semanticscholar.org/paper/Cannabinoid-CB1-receptors-in-distinct-circuits-of-Lange-Daldrup/55525d456fbda15105445d254f3e6f6d3a430642 
• Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex. (Germany, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0028390816304580 
• Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack. (Brazil, abstract, 2016) https://www.sciencedirect.com/science/article/pii/S0166432816307999 
• Targeting the Endocannabinoid System in Psychiatric Illness. (Canada, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27811555/ 
• Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis. (Canada, abstract, 2016) https://www.semanticscholar.org/paper/Attitudes-to-cannabis-and-patterns-of-use-among-Banwell-Pavisian/d6b1312f0d1dca1ed8eef6859683fb35e9145d41 
• Investigational drugs for treating agitation in persons with dementia. (France/ USA, abstract, 2016) https://www.semanticscholar.org/paper/Investigational-drugs-for-treating-agitation-in-Garay-Citrome/822a91ef37596c81031c95037b377631a4e11673 
• The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay. (USA, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27710762/ 
• LACTIC ACIDOSIS: A RARE MANIFESTATION OF SYNTHETIC MARIJUANA INTOXICATION. (USA, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27159480/ 
• Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. (Italy, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/26970364/        
• Treating Depression in Alcoholics (news & abst–2016)  http://neurosciencenews.com/alcoholism-depression-psychology-3541/
• Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
• Cannabis Compares Favorably to Conventional PTSD Treatments (news–2016) http://www.prweb.com/releases/2016/03/prweb13244763.htm
• High Anxiety Risk in Adolescence Linked to One Gene (news–2016)
  http://www.livescience.com/54111-anxiety-risk-linked-to-gene.html
• Smoking cannabis DOESN’T cause clinical anxiety or depression, study finds (news–2016) http://www.dailymail.co.uk/news/article-3456326/Smoking-cannabis-DOESN-T-cause-clinical-anxietydepression.html#ixzz45lywpZ11
• How Cannabis Works to Control Pain and Anxiety (news–2016)
  http://www.huffingtonpost.com/entry/how-cannabis-works-to-control-pain-andanxiety_us_57d97a73e4b0d93d17700f63
• Pet owners try cannabis edibles, tinctures to ease animal anxiety, arthritis and more (news–2016) http://www.thecannifornian.com/cannabis-health/pet-owners-try-edibles-ease-anxiety-arthritis/
• Marijuana Appears to Benefit Mental Health: Study (news–2016) http://time.com/4573129/marijuana-cannabis-mental-health/
• Why Chauncey Billups was totally cool with NBA teammates smoking weed before games (news–2016) http://www.thecannabist.co/2016/12/13/chauncey-billups-teammates-smoking-marijuana/69273/
• Study Reveals Role of Spleen in Prolonged Anxiety After Stress (news–2016)
  http://neurosciencenews.com/stress-anxiety-spleen-5507/
• 2015
• Cannabinoid Receptors May Control Aversive Memories (news & abstract-2015) http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
• Teen marijuana use not linked to later depression, lung cancer, other health problems, study finds (news–2015)
  http://www.sciencedaily.com/releases/2015/08/150804093718.htm
• Is Anxiety Genetic? (news–2015)
  http://www.quickanddirtytips.com/education/science/is-anxiety-genetic
• 5 Prescription Drugs That Could Literally Replaced by Marijuana (news–2015) http://blogs.naturalnews.com/5-prescription-drugs-literally-replaced-marijuana/
• Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity. (USA/ China, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517601/ 
• Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system. (Brazil, full, 2015) https://academic.oup.com/ijnp/article/18/8/pyv005/2910011 
• Marijuana Legalization: Impact on Physicians and Public Health. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900958/ 
• Longitudinal associations between social anxiety symptoms and cannabis use throughout adolescence: the role of peer involvement. (Netherlands, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854944/ 
• Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms. (Canada/ USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/ 
• Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (Spain/ France/ USA, full, 2015) https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194 
• FAAH genetic variation enhances fronto-amygdala function in mouse and human. (USA/ Canada, full, 2015) https://www.nature.com/articles/ncomms7395 
• Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxietylike behavior and unaltered seizure susceptibility. (Germany/ Australia, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772822/ 
• The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA. (Iran, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669909/ 
• Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety. (Italy/ Germany, full, 2015) https://www.nature.com/articles/srep18218 
• Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586320/ 
• Neural correlates of cannabidiol and Δ9-tetrahydrocannabinol interactions in mice: implications for medical cannabis. (Australia, full, 2015) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.13333 
• Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety. (Italy, full, 2015) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0137034 
• Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder. (USA, full, 2015) https://molecularbrain.biomedcentral.com/articles/10.1186/s13041-015-0104-3 
• Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety. (Canada/ USA/ Germany, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348185/ 
• Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxietylike behavior and sociability. (Germany, full, 2015) https://www.frontiersin.org/articles/10.3389/fnbeh.2015.00235/full 
• Developmental regulation of fear learning and anxiety behavior by endocannabinoids. (Canada/ USA, full, 2015) https://onlinelibrary.wiley.com/doi/full/10.1111/gbb.12253 
• Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling. (Canada/ France, full, 2015) https://www.cell.com/neuron/fulltext/S0896-6273(15)00130-0 
• A runner's high depends on cannabinoid receptors in mice. (Germany, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620874/ 
• Mechanisms of stress in the brain. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933289/ 
• Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646225/ 
• Cannabidiol as a Potential Treatment for Anxiety Disorders. (USA/ Spain, full, 2015) https://link.springer.com/article/10.1007/s13311-015-0387-1 
• Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats. (USA, full, 2015) https://www.sciencedirect.com/science/article/pii/S0091305715300885 
• Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels. (Germany, full, 2015) https://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00314-5/fulltext 
• Cannabis use, depression and anxiety: A 3-year prospective population-based study. (Sweden, full, 2015) https://www.sciencedirect.com/science/article/pii/S0165032715310302 
• Genetic deletion of monoacylglycerol lipase (MAGL) leads to impaired cannabinoid receptor CB1 R signaling and anxiety-like behavior. (Italy/ Austria, full, 2015) https://onlinelibrary.wiley.com/doi/full/10.1111/jnc.13267 
• Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats. (USA/ Italy, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793117/ 
• Behavioral genetics: of mice, men, and internal bliss. (USA, full, 2015) https://www.cell.com/current-biology/fulltext/S0960-9822(15)00414-5 
• The endocannabinoid system in guarding against fear, anxiety and stress. (Germany/ France/ Spain/ USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871913/ 
• Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912876/ 
• Cannabis in cancer care. (USA/ Spain, full, 2015) https://escholarship.org/uc/item/6367m6vj#page-1 
• Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences. (Brazil, full, 2015) https://docksci.com/effects-of-intra-infralimbic-prefrontal-cortex-injections-of-cannabidiol-in-the-_5a62c735d64ab2c4e6b72006.html 
• The basolateral amygdala γ-aminobutyric acidergic system in health and disease. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837071/ 
• Habenular CB1 Receptors Control the Expression of Aversive Memories. (France/ China, full, 2015) https://www.cell.com/neuron/fulltext/S0896-6273(15)00729-1 
• Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724469/ 
• Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580823/ 
• 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. (Spain/ Germany/ Italy/ Czech Republic, link to PDF, 2015) https://www.researchgate.net/publication/274258130_2-AG_promotes_the_expression_of_conditioned_fear_via_cannabinoid_receptor_type_1_on_GABAergic_neurons 
• Effects of CB1 receptor agonism and antagonism on behavioural fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats. (Canada, link to PDF, 2015) https://www.researchgate.net/publication/281342219_Effects_of_CB1_receptor_agonism_and_antagonism_on_behavioral_fear_and_physiological_stress_responses_in_adult_intact_ovariectomized_and_estradiol-replaced_female_rats 
• Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses. (Brazil, link to PDF, 2015) https://www.researchgate.net/publication/271334260_Role_of_endocannabinoid_signalling_in_the_dorsolateral_periaqueductal_grey_in_the_modulation_of_distinct_panic-like_responses 
• Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea. (UK, link to PDF, 2015) https://www.researchgate.net/publication/282765943_Neuromotor_tolerability_and_behavioural_characterisation_of_cannabidiolic_acid_a_phytocannabinoid_with_therapeutic_potential_for_anticipatory_nausea 
•  Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others. (Spain, download, 2015) https://www.cannabismedicinal.com.ar/images/documentos/Investigacion/ChapterPertwee_2015.pdf 
• The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review. (USA/ Italy, download, 2015) https://www.researchgate.net/profile/Greg_Goddard2/publication/272406849_The_Effectiveness_of_Cannabinoids_in_the_Management_of_Chronic_Nonmalignant_Neuropathic_Pain_A_Systematic_Review/links/565e6aa308aeafc2aac8fa9c.pdf 
• Endocannabinoid regulation of amyloid-induced neuroinflammation. (Spain/ USA, click “ufves” for download, 2015) https://scholar.google.com/scholar?q=Endocannabinoid+regulation+of+amyloid-induced+neuroinflammation&hl=en&as_sdt=0&as_vis=1&oi=scholart 
• Stress and memory: A selective review on recent developments in the understanding of stress hormone effects on memory and their clinical relevance. (Germany/ Netherlands/ Switzerland, click “rubde” for download, 2015) https://scholar.google.com/scholar?cluster=10129264874041443223&hl=en&as_sdt=0,5 
• Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence. (Brazil, click “theroc” for download, 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Cannabinoid+CB1+receptors+in+the+dorsal+hippocampus+and+prelimbic+medial+prefrontal+cortex+modulate+anxiety-like+behavior+in+rats%3A+additional+evidence.++++++++%22&btnG 
• Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. (USA, click “semanticscholar” for download, 2015) https://scholar.google.com/scholar?q=%22Use+and+effects+of+cannabinoids+in+military+veterans+with+posttraumatic+stress+disorder+%22&hl=en&as_sdt=0&as_vis=1&oi=scholart 
•  Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey. (Brazil, abstract, 2015) https://www.semanticscholar.org/paper/Role-of-the-endocannabinoid-2-arachidonoylglycerol-Gobira-Almeida-Santos/4af816a27b4d6fc1e1905736d6552c8b61ae1045 
• Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression. (China, abstract, 2015) https://www.sciencedirect.com/science/article/pii/S0091305715000283 
• Central administration of GPR55 receptor agonist and antagonist modulates anxiety related behaviors in rats. (Iran, abstract, 2015) https://www.semanticscholar.org/paper/Central-administration-of-GPR55-receptor-agonist-in-Rahimi-Moghaddam/d056ca05ce2ef0ba0853de4606aa3e14c356e50c 
• Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice. (Canada, abstract, 2015) https://www.sciencedirect.com/science/article/pii/S0166432815001047 
• The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs-A practical view. (Sweden, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/25791296/ 
• Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1- endoccannabinoid receptor in the ventral mesencephalon. (Brazil, abstract, 2015) https://www.sciencedirect.com/science/article/abs/pii/S001429991500268X?via%3Dihub 
• Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio). (Brazil, abstract, 2015) https://www.sciencedirect.com/science/article/pii/S0091305715300186 
• Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper snake. (Brazil, abstract, 2015) https://www.sciencedirect.com/science/article/abs/pii/S0306452215005898 
• The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors. (Brazil, abstract, 2015) https://www.sciencedirect.com/science/article/pii/S0166432815300863 
• Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice. (Brazil, abstract, 2015) https://www.sciencedirect.com/science/article/abs/pii/S027858461530004X 
• Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease. (Canada, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/26271310/ 
• Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning. (Iran, abstract, 2015) https://www.sciencedirect.com/science/article/pii/S0166432815303259 
• The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus. (Canada/ Italy, abstract, 2015) https://www.sciencedirect.com/science/article/abs/pii/S0924977X15004101?via%3Dihub 
• Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students. (USA, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/26449928/ 
• Mediating processes between stress and problematic marijuana use. (USA, abstract, 2015) https://www.sciencedirect.com/science/article/abs/pii/S0306460315000167 
• Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans. (USA, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/25034429/ 
• CB1 receptors into the Prelimbic Cortex modulate food intake in rats. (Brazil, abstract, 2015) https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fasebj.29.1_supplement.655.1 
• Advancements in the treatment of agitation in Alzheimer's disease. (USA, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/26159445/ 
• A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA. (USA, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/25726258/ 
• 2014
• Discovery Sheds New Light on Marijuana’s Anxiety Relief Effects (news–2014)
  http://neurosciencenews.com/cannabinoid-receptors-amygdala-anxiety-833/
• Marijuana’s anxiety relief effects: Receptors found in emotional hub of brain (news–2014) http://www.sciencedaily.com/releases/2014/03/140306142803.htm
• How Black Pepper relieves Cannabis Anxiety (news–2014) http://cannabisdigest.ca/black-pepper-relieves-cannabis-anxiety/
• The surprising everyday ingredient that can reduce pot paranoia (news–2014)
  http://www.salon.com/2014/08/21/the_surprising_everyday_ingredient_that_can_reduce_pot_paranoia_partner/
• Natural ‘high’ could avoid chronic marijuana use, Vanderbilt study finds (news–2014)
  http://news.vanderbilt.edu/2014/12/natural-high-could-avoid-chronic-marijuana-use-vanderbilt-study-finds/
• Activating cannabinoid brain receptors could replace marijuana for anxiety treatment (news–2014) http://www.medicalnewstoday.com/articles/286482.php
• Cannabis Prevents the Negative Behavioral and Physiological Effects PTSD (news – 2014) http://neurosciencenews.com/neuropharmacology-cannabinoids-ptsd-1300/
• 2013
• Hashing It Out In Ohio With The Martha Stewart Of Marijuana (interview–2013)  http://blog.themobilityresource.com/blog/post/cheryl-shuman-tours-with-the-ohio-rights-group
• Potential new way to treat anxiety (news–2013)  http://www.medicalnewstoday.com/releases/264392.php
• Terpenes May Improve Effectiveness Of Medical Marijuana (news–2013) http://www.medicaljane.com/2013/09/23/terpenes-may-improve-effectiveness-of-medical-marijuana/#
• Could Marijuana Use Lead To A Calmer Prison Environment? Swiss Prisons Find Drug’s Effects On Inmates Positive (news–2013) http://www.medicaldaily.com/could-marijuana-use-lead-calmer-prison-environment-swiss-prisons-find-drugs-effects-inmates-positive
• Psychological Benefits Of Marijuana Usage (news–2013)  http://mentalhealthdaily.com/2013/03/05/psychological-benefits-of-marijuana-usage/
• 2011
• New Findings on How the Brain’s Own Marijuana-Like Chemicals Suppress Pain (news–2011) https://www.nuigalway.ie/about-us/news-and-events/news-archive/2011/october2011/new-findings-on-how-the-brains-own-marijuana-like-chemicals-suppress-pain.html
• Omega 3s, Mice, and Receptors for Funny Cigarettes (news–2011)  http://evolutionarypsychiatry.blogspot.com/2011/04/omega-3s-mice-and-receptors-for-funny.html